The potential application of finasteride for chemoprevention of prostate cancer.
Merck Research Laboratories, Rahway, New Jersey 07065, USA.
G J
GJ
Gormley
O
O
Brawley
I
I
Thompson
D058891:5-alpha Reductase Inhibitors; D000818:Animals; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011467:Prostate / Q000187:drug effects / Q000502:physiology; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000517:prevention & control*
D058891:5-alpha Reductase Inhibitors; D016588:Anticarcinogenic Agents; D004791:Enzyme Inhibitors; D018120:Finasteride; D017430:Prostate-Specific Antigen